XML 46 R33.htm IDEA: XBRL DOCUMENT
v3.22.0.1

License and Collaboration Agreements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
License, Collaboration and Other Revenue | In accordance with our collaboration agreements, we recognized license, collaboration and other revenue as follows (in thousands):
|  |  |  | Year Ended December 31,
Partner |  | Agreement |  | 2021 |  | 2020 |  | 2019
Bristol-Myers Squibb |  | Bempegaldesleukin |  | $ | — |  |  | $ | 50,000 |  |  | $ | — |
Eli Lilly and Company |  | NKTR-358 |  | — |  |  | 1,259 |  |  | 7,019 |
Amgen, Inc. |  | Neulasta® |  | — |  |  | 4,167 |  |  | 5,000 |
Other |  |  |  | 436 |  |  | 423 |  |  | 4,956 |
License, collaboration and other revenue |  |  |  | $ | 436 |  |  | $ | 55,849 |  |  | $ | 16,975 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 + Details
Name: | us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration